Clinical Trials in Georgia

Showing 4001-4020 of 19,050 trials

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

NCT05367960

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).

Fragile X Syndrome

Tetra Discovery Partners314 participantsStarted Nov 2022

Irvine, California, United States • Orange, California, United States • Sacramento, California, United States +14 more locations

No Longer Available65 miles

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

NCT05095116

This expanded access program is an open-label, single-arm design where consenting patients may participate up until APT-1011 is commercially available in the relevant regions or the protocol is terminated by the Sponsor.

Eosinophilic Esophagitis

Ellodi Pharmaceuticals, LP

Tucson, Arizona, United States • North Little Rock, Arkansas, United States • Camarillo, California, United States +32 more locations

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Find Trials by Condition in Georgia

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

Improving Outcomes Assessment in Chronic GVHD

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Hyperbaric Oxygen Brain Injury Treatment Trial

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

VItamin C in Thermal injuRY: The VICToRY Trial

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery